New scanners prompt Fonar's RSNA return

Article

After a six-year absence from the RSNA technical spotlight MRIvendor Fonar is planning to return to radiology's spotlight witha family of new MRI scanners and momentum from its recent courtvictories in patent litigation with GE. In a jury trial in

After a six-year absence from the RSNA technical spotlight MRIvendor Fonar is planning to return to radiology's spotlight witha family of new MRI scanners and momentum from its recent courtvictories in patent litigation with GE.

In a jury trial in federal court earlier this year, Fonar ofMelville, NY, won a ruling that GE infringed on two patents grantedto Fonar founder Dr. Raymond Damadian. The two sides continueto wrangle over appeals to the verdict (SCAN 10/25/95).

Fonar hopes to use the jury award, along with cash from a settlementof litigation with Hitachi, to fund a comeback in the MRI industry.At the RSNA meeting, Fonar will display its Quad family, whichincludes the 0.35-tesla Quad 7000 and the 0.6-tesla Quad 12000.

Fonar will emphasize the openness of Quad 7000 and its suitabilityfor obese and claustrophobic patients. The company also plansto highlight Quad 7000's potential in delivering cost-effectiveMR mammography.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.